|
1
|
Zhou LF, Zhang MX, Kong LQ, Lyman GH, Wang
K, Lu W, Feng QM, Wei B and Zhao LP: Costs, trends and related
factors in treating lung cancer patients in 67 hospitals in
Guangxi, China. Cancer Invest. 35:345–357. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Siegel R, Ma J, Zou Z and Jemal A: Cancer
statistics, 2014. CA Cancer J Clin. 64:9–29. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Sachdeva M, Sachdeva N, Pal M, Gupta N,
Khan IA, Majumdar M and Tiwari A: CRISPR/Cas9: Molecular tool for
gene therapy to target genome and epigenome in the treatment of
lung cancer. Cancer Gene Ther. 22:509–517. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Reddy C, Chilla D and Boltax J: Lung
cancer screening: A review of available data and current
guidelines. Hosp Pract (1995). 39:107–112. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Liu X, Sempere LF, Guo Y, Korc M,
Kauppinen S, Freemantle SJ and Dmitrovsky E: Involvement of
MicroRNAs in lung cancer biology and therapy. Transl Res.
157:200–208. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Bhattacharjee A, Richards WG, Staunton J,
Li C, Monti S, Vasa P, Ladd C, Beheshti J, Bueno R, Gillette M, et
al: Classification of human lung carcinomas by mRNA expression
profiling reveals distinct adenocarcinoma subclasses. Proc Natl
Acad Sci USA. 98:pp. 13790–13795. 2001; View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Beer DG, Kardia SL, Huang CC, Giordano TJ,
Levin AM, Misek DE, Lin L, Chen G, Gharib TG, Thomas DG, et al:
Gene-expression profiles predict survival of patients with lung
adenocarcinoma. Nat Med. 8:816–824. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Guo WF, Lin RX, Huang J, Zhou Z, Yang J,
Guo GZ and Wang SQ: Identification of differentially expressed
genes contributing to radioresistance in lung cancer cells using
microarray analysis. Radiat Res. 164:27–35. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Tantai JC, Pan XF and Zhao H: Network
analysis of differentially expressed genes reveals key genes in
small cell lung cancer. Eur Rev Med Pharmacol Sci. 19:1364–1372.
2015.PubMed/NCBI
|
|
10
|
Wachi S, Yoneda K and Wu R:
Interactome-transcriptome analysis reveals the high centrality of
genes differentially expressed in lung cancer tissues.
Bioinformatics. 21:4205–4208. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Lv M and Wang L: Comprehensive analysis of
genes, pathways, and TFs in nonsmoking Taiwan females with lung
cancer. Exp Lung Res. 41:74–83. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Ritchie ME, Phipson B, Wu D, Hu Y, Law CW,
Shi W and Smyth GK: Limma powers differential expression analyses
for RNA-sequencing and microarray studies. Nucleic Acids Res.
43:e472015. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Hsia CW, Ho MY, Shui HA, Tsai CB and Tseng
MJ: Analysis of dermal papilla cell interactome using STRING
database to profile the ex vivo hair growth inhibition effect of a
vinca alkaloid drug, colchicine. Int J Mol Sci. 16:3579–3598. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Jenjaroenpun P and Kuznetsov VA: TTS
mapping: Integrative WEB tool for analysis of triplex formation
target DNA sequences, G-quadruplets and non-protein coding
regulatory DNA elements in the human genome. BMC Genomics. 10 Suppl
3:S92009. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Yesner R and Matthews MJ: World health
organization lung cancer classification: pathology of lung cancer.
Chest. 89 Suppl:315S1986. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Hudy MH, Traves SL, Wiehler S and Proud D:
Cigarette smoke modulates rhinovirus-induced airway epithelial cell
chemokine production. Eur Respir J. 35:1256–1263. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Zheng L, Jiang G, Mei H, Pu J, Dong J, Hou
X and Tong Q: Small RNA interference-mediated gene silencing of
heparanase abolishes the invasion, metastasis and angiogenesis of
gastric cancer cells. BMC Cancer. 10:332010. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
McCormack MP, Young LF, Vasudevan S, de
Graaf CA, Codrington R, Rabbitts TH, Jane SM and Curtis DJ: The
Lmo2 oncogene initiates leukemia in mice by inducing thymocyte
self-renewal. Science. 327:879–883. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Yamada Y, Pannell R, Forster A and
Rabbitts TH: The LIM-domain protein Lmo2 is a key regulator of
tumour angiogenesis: A new anti-angiogenesis drug target. Oncogene.
21:1309–1315. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Han SA, Song JY, Min SY, Park WS, Kim MJ,
Chung JH and Kwon KH: A genetic association analysis of
polymorphisms, rs2282695 and rs12373539, in the FOSB gene and
papillary thyroid cancer. Exp Ther Med. 4:519–523. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Shahzad MM, Arevalo JM, Armaiz-Pena GN, Lu
C, Stone RL, Moreno-Smith M, Nishimura M, Lee JW, Jennings NB,
Bottsford-Miller J, et al: Stress effects on FosB- and
interleukin-8 (IL8)-driven ovarian cancer growth and metastasis. J
Biol Chem. 285:35462–35470. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Vella LJ: The emerging role of exosomes in
epithelial-mesenchymal-transition in cancer. Front Oncol.
4:3612014. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Pei L and Melmed S: Isolation and
characterization of a pituitary tumor-transforming gene (PTTG). Mol
Endocrinol. 11:433–441. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Smith VE, Franklyn JA and McCabe CJ:
Pituitary tumor-transforming gene and its binding factor in
endocrine cancer. Expert Rev Mol Med. 12:e382010. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Salehi F, Kovacs K, Scheithauer BW, Lloyd
RV and Cusimano M: Pituitary tumor-transforming gene in endocrine
and other neoplasms: A review and update. Endocr Relat Cancer.
15:721–743. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Yasuyuki S, Nobuhiro H, Yoshiyuki K,
Nishiwaki T, Kato J, Shinoda N, Sato A, Kimura M, Koyama H, Toyama
T, et al: Expression of PTTG (pituitary tumor transforming gene) in
esophageal cancer. Jpn J Clin Oncol. 32:233–237. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Xin DQ, Zhu XH, Lai YQ, You R, Na YQ, Guo
YL and Mao ZB: Regulation of expression of pituitary tumor
transforming gene 1 (PTTG1) by androgen in prostate cancer. Beijing
Da Xue Xue Bao. 37:638–640. 2005.(In Chinese). PubMed/NCBI
|
|
29
|
Mu YM, Oba K, Yanase T, Ito T, Ashida K,
Goto K, Morinaga H, Ikuyama S, Takayanagi R and Nawata H: Human
pituitary tumor transforming gene (hPTTG) inhibits human lung
cancer A549 cell growth through activation of p21 (WAF1/CIP1).
Endocr J. 50:771–781. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Chen CC, Chang TW, Chen FM, Hou MF, Hung
SY, Chong IW, Lee SC, Zhou TH and Lin SR: Combination of multiple
mRNA markers (PTTG1, Survivin, UbcH10 and TK1) in the diagnosis of
Taiwanese patients with breast cancer by membrane array. Oncology.
70:438–446. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Kim DS, Franklyn JA, Stratford AL,
Boelaert K, Watkinson JC, Eggo MC and McCabe CJ: Pituitary
tumor-transforming gene regulates multiple downstream angiogenic
genes in thyroid cancer. J Clin Endocrinol Metab. 91:1119–1128.
2006. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Kim JW, Song JY, Lee JM, Lee JK, Lee NW,
Yeom BW and Lee KW: Expression of pituitary tumor-transforming gene
in endometrial cancer as a prognostic marker. Int J Gynecol Cancer.
18:1352–1359. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Yoon CH, Kim MJ, Lee H, Kim RK, Lim EJ,
Yoo KC, Lee GH, Cui YH, Oh YS, Gye MC, et al: PTTG1 oncogene
promotes tumor malignancy via epithelial to mesenchymal transition
and expansion of cancer stem cell population. J Biol Chem.
287:19516–19527. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Lewy GD, Ryan GA, Read ML, Fong JC, Poole
V, Seed RI, Sharma N, Smith VE, Kwan PP, Stewart SL, et al:
Regulation of pituitary tumor transforming gene (PTTG) expression
and phosphorylation in thyroid cells. Endocrinology. 154:4408–4422.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
McCabe CJ, Khaira JS, Boelaert K, Heaney
AP, Tannahill LA, Hussain S, Mitchell R, Olliff J, Sheppard MC,
Franklyn JA and Gittoes NJ: Expression of pituitary tumour
transforming gene (PTTG) and fibroblast growth factor-2 (FGF-2) in
human pituitary adenomas: Relationships to clinical tumour
behaviour. Clin Endocrinol (Oxf). 58:141–150. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Malik MT and Kakar SS: Regulation of
angiogenesis and invasion by human Pituitary tumor transforming
gene (PTTG) through increased expression and secretion of matrix
metalloproteinase-2 (MMP-2). Mol Cancer. 5:612006. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Hamid T and Kakar SS: PTTG/securin
activates expression of p53 and modulates its function. Mol Cancer.
3:182004. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Cho-Rok J, Yoo J, Jang YJ, Kim S, Chu IS,
Yeom YI, Choi JY and Im DS: Adenovirus-mediated transfer of siRNA
against PTTG1 inhibits liver cancer cell growth in vitro and in
vivo. Hepatology. 43:1042–1052. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Chirco R, Liu XW, Jung KK and Kim HR:
Novel functions of TIMPs in cell signaling. Cancer Metastasis Rev.
25:99–113. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Sheu BC, Hsu SM, Ho HN, Lien HC, Huang SC
and Lin RH: A novel role of metalloproteinase in cancer-mediated
immunosuppression. Cancer Res. 61:237–242. 2001.PubMed/NCBI
|
|
41
|
Bergers G, Brekken R, Mcmahon G, Vu TH,
Itoh T, Tamaki K, Tanzawa K, Thorpe P, Itohara S, Werb Z and
Hanahan D: Matrix metalloproteinase-9 triggers the angiogenic
switch during carcinogenesis. Nat Cell Biol. 2:737–744. 2000.
View Article : Google Scholar : PubMed/NCBI
|
|
42
|
El-Badrawy MK, Yousef AM, Shaalan D and
Elsamanoudy AZ: Matrix metalloproteinase-9 expression in lung
cancer patients and its relation to serum mmp-9 activity,
pathologic type, and prognosis. J Bronchology Interv Pulmonol.
21:327–334. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Cheng X, Yang Y, Fan Z, Yu L, Bai H, Zhou
B, Wu X, Xu H, Fang M, Shen A, et al: MKL1 potentiates lung cancer
cell migration and invasion by epigenetically activating MMP9
transcription. Oncogene. 34:5570–5581. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Li L, Tan J, Zhang Y, Han N, Di X, Xiao T,
Cheng S, Gao Y and Liu Y: DLK1 promotes lung cancer cell invasion
through upregulation of MMP9 expression depending on notch
signaling. PLoS One. 9:e915092014. View Article : Google Scholar : PubMed/NCBI
|
